Home Tools
Log in
Cart

Search Result

Search Results for " rgd peptide "

20

Compounds

Cat No. Product Name Synonyms Targets
T7570 RGD peptide (GRGDNP) RGD peptide GRGDNP(2TFA),RGD peptide GRGDNP Apoptosis , Integrin
RGD peptide (GRGDNP) (RGD peptide GRGDNP(2TFA)) is a integrin-ligand interactions inhibitor.
TP1311 RGD peptide (GRGDNP) (TFA) (114681-65-1 free base) RGD peptide (GRGDNP) (TFA)
RGD peptide (GRGDNP) (TFA) promote apoptosis through activation of conformation changes that enhance pro-caspase-3 activation and autoprocessing.
T81283 RGD-targeted Proapoptotic Peptide
RGD-Targeted Proapoptotic Peptide is a peptide that preferentially binds to integrins at sites of tumor angiogenesis through its C-terminal RGD-4C sequence (ACDCRGDCFC).
T76007 RGD peptide (GRGDNP) (TFA)
RGD peptide (GRGDNP) TFA functions as an inhibitor of integrin-ligand interactions, competitively blocking α5β1's interaction with the extracellular matrix (ECM). It induces apoptosis by triggering conformational changes...
T7566L GRGDSPK 2TFA(111119-28-9(free base)) EMD 56574 Others
GRGDSPK 2TFA(111119-28-9(free base)) (EMD 56574) is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
TP1290 GRGDSP acetate(91037-75-1 free base) GRGDSP TFA Integrin
GRGDSP acetate(91037-75-1 free base) is a synthetic linear RGD peptide and is an integrin inhibitor.
TP1458L Arg-Gly-Glu-Ser acetate(93674-97-6 free base) Others
Arg-Gly-Glu-Ser acetate is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets.
TP1330 Cyclo(RADfK) Integrin
Cyclo(RADfK) is a selective α(v)β(3) integrin ligand that has been extensively used for research, therapy, and diagnosis of neoangiogenesis.Cyclo(RADfK) is a negative control for the cyclo (-RGDfK-), the RGD peptide. RGD...
TP1696L CGGRGD acetate(1260223-44-6 free base) Others
CGGRGD acetate is a RGD derivative with cysteine as the n-terminal. CGGRGD was synthesized by solid phase peptide synthesis technology, and amino2-cyanobenzothiazole (2-cyanobenzothiazole) (2-cyanobenzothiazole (CBT) was...
TP1530L YRGDS Fibronectin Fragment acetate YRGDS Fibronectin Fragment acetate(134282-68-1 free base) Others
YRGDS Fibronectin Fragment acetate (YRGDS Fibronectin Fragment acetate (134282-68-1 free base))(134282-68-1 free base) is a fibronectin fragment acetate, an adhesion peptide that displays strong binding affinity to throm...
TP1474 LXW7 Integrin
LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-pepti...
T24796 SK&F 107260 Skf107260,Skf-107260,Skf 107260
SK&F 107260 is an RGD-containing peptide. It is a potent GP IIb/IIIa antagonist and a vitronectin antagonist.
T24896 TP 9201 TP-9201,TP9201
TP 9201 is a platelet integrin alphaIIbbeta3 antagonist. It is a synthetic RGD-containing cyclic peptide.
TP1530 YRGDS Fibronectin Fragment
This is a fibronectin fragment, an adhesion peptide that displays strong binding affinity to thrombin-stimulated platelets. It is RGD consisting of sequence.
T7566 GRGDSPK EMD 56574 Others
GRGDSPK (EMD 56574) is an inhibitory peptide for RGD-mediated adhesion between integrin and extracellular matrix molecules.
TP1421 GRGDSP
Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) is used as a soluble integrin-blocking RGD-based peptide.
T80075 Cyclo(Ala-Arg-Gly-Asp-Mamb) XJ735 Integrin
Cyclo(Ala-Arg-Gly-Asp-Mamb) is a selective antagonist of the RGD peptide with potential applications in pulmonary arterial hypertension research [1].
TP1489 Risuteganib
Risuteganib is a synthetic RGD (arginyl-glycyl-aspartic acid)-class peptide that regulates the functions of multiple integrin isoforms.
T78001 Arg-Gly-Glu-Ser TFA
Arg-Gly-Glu-Ser TFA, an RGD-related peptide, serves as a control for evaluating the inhibitory activity of RGDS on fibrinogen binding to activated platelets.
TP1458 Arg-Gly-Glu-Ser
Arg-Gly-Glu-Ser is a RGD related peptide that is a control for the RGDS activity of fibrinogen binding to activated platelets.
1 2
TargetMol